Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study (vol 70, pg 526, 2009)

被引：0
|
作者：
Cutler, Andrew J.
机构：
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2009年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1729 / 1729
页数：1
相关论文
共 50 条
  • [1] Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study
    Cutler, Andrew J.
    Montgomery, Stuart A.
    Feifel, David
    Lazarus, Arthur
    Astrom, Mikael
    Brecher, Martin
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 526 - 539
  • [2] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study
    Bortnick, Brian
    El-Khalili, Nizar
    Banov, Michael
    Adson, David
    Datto, Catherine
    Raines, Shane
    Earley, Willie
    Eriksson, Hans
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 128 (1-2) : 83 - 94
  • [3] Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study
    Weisler, Richard
    Joyce, J. Mark
    McGill, Lora
    Lazarus, Arthur
    Szamosi, Johan
    Eriksson, Hans
    CNS SPECTRUMS, 2009, 14 (06) : 299 - 313
  • [4] A randomised, placebo-controlled study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 332 - 333
  • [5] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A randomized, placebo-controlled clinical trial (study 003)
    El-Khalili, Nizar
    Banov, Michael
    Bortnick, Brian
    Adson, David
    Datto, Catherine
    Raines, Shane
    Earley, Willie
    Brecher, Martin
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 297S - 297S
  • [6] Extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S259 - S260
  • [7] EFFICACY AND TOLERABILITY OF EXTENDED RELEASE QUETIAPINE FUMARATE MONOTHERAPY AS MAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Liebowitz, Michael
    Lam, Raymond W.
    Lepola, Ulla
    Datto, Catherine
    Sweitzer, Dennis
    Eriksson, Hans
    DEPRESSION AND ANXIETY, 2010, 27 (10) : 964 - 976
  • [8] Extended release quetiapine fumarate monotherapy as maintenance treatment in patients with major depressive disorder (MDD)
    Datto, C.
    Lam, R. W.
    Lepola, U.
    Sweitzer, D.
    Eriksson, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S377 - S378
  • [9] The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder
    Weisler, Richard
    McIntyre, Roger S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (11) : 1161 - 1182
  • [10] Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy on sleep disturbance in patients with major depressive disorder
    Papakostas, G.
    Bandelow, B.
    Demyttenaere, K.
    Trivedi, M.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 159 - 159
12345